Simplified disease activity index as an index of disease activity in patients with rheumatoid arthritis: A comparison with DAS28

Indian Journal of Rheumatology

Volumn 4, Issue 1, 2009, Pages 11-14

  Sharma, R ^a   Thakare, M ^a   Thomas, J ^a   Agrawal, S ^a   Rajasekhar, L ^a   Narsimulu, G ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

DAS28; Disease activity index; Rheumatoid arthritis; SDAI

Indexed keywords

C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEALTH CARE FACILITY; HEALTH STATUS; HUMAN; INDIA; INDIAN; INTERMETHOD COMPARISON; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; ROC CURVE; SENSITIVITY AND SPECIFICITY; VISUAL ANALOG SCALE;

EID: 84992234299     PISSN: 09733698     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0973-3698(10)60155-0     Document Type: Article

References (12)

1. Pincus T. The American College of Rheumatology (ACR) Core Data Set and derivative "patient only" indices to assess rheumatoid arthritis. Clin Exp Rheumatol 2005; 23(Suppl 39): S109-13.
2. Felson DT, Anderson JJ, Boers M, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 1993; 36: 729-40.
3. Atelaha D. Pooled indices to measure rheumatoid arthritis activity: a good reflection of the physician's mind? Arthritis Res Ther 2006; 8: 102.
4. Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, van Riel PL, Tugwell P. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology 2003; 42: 244-57.
5. Smolen JS. The work of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT). Br J Rheumatol 1992; 31: 219-20.
6. Boers M, Tugwell P, Felson DT, et al. World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol 1994; 41(Suppl): 86-9.
7. Leeb BF, Andel I, Sautner J, Bogdan M, Maktari A, Nothnagl T, Rintelen B. Disease activity measurement of rheumatoid arthritis: comparison of the Simplified Disease Activity Index (SDAI) and the Disease Activity Score Including 28 joints (DAS28) in daily routine. Arthritis Rheum (Arthritis Care Res) 2005; 53: 56-60.
8. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries DJ, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
9. Aletaha D, Nell VPK, Stamm T, Uffmann M, Pflugbeil S, Machold K, Smolen JS. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 2005; 7: R796-806.
10. Aletaha D, Smolen JS. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 2005; 23(Suppl 39): S100-8.
11. Van Riel PL. Disease activity score in rheumatoid arthritis. http://www.dayas-score.nL/www.das-score.nl/index html. (Date accessed: September 2005)
12. Antoni C, Maini RN, Grunke M, et al. Cooperative on quality of life in rheumatic diseases: results of a survey among 6000 patients across 11 European countries. Arthritis Rheum 2002; 46(Suppl) (Abstract).